- Attended as a representative of a 안전한 바카라 사이트n ‘unicorn’ company… Outlined the direction of bilateral cooperation and key initiatives
- Meeting with investors at the Korea-안전한 바카라 사이트 Investment Conference and Global Fund Inauguration… "Exploring opportunities to secure tangible investment"
[by Jin, Yu Jeong] Lunit, a developer of medical artificial intelligence (AI), announced on January 8 that it participated as a representative Korean unicorn company in the ‘Korea-China Venture Startup Summit,’ held as part of President Lee Jae-myung's official visit to China.
Hosted at the Shanghai International Exhibition Center in 안전한 바카라 사이트 and organized by the Ministry of SMEs and Startups, the summit brought together approximately 400 participants, including President Lee, Senior Presidential Secretary for Policy Kim Yong-beom, Deputy Prime Minister and Minister of Science and ICT Bae Kyung-hoon, Minister of SMEs and Startups Han Seong-sook, the Chinese Ambassador to Korea, the Korean Ambassador to 안전한 바카라 사이트, the Deputy Mayor of Shanghai, and other government officials, as well as representatives from leading technology companies and investment institutions from both Korea and 안전한 바카라 사이트.
Brandon Beom-seok Suh, CEO of Lunit, participated in the ‘Korea-China Venture Startup Dialogue’ hosted by the President, where he engaged in a high-level discussion as a representative of Korean unicorn companies. Alongside the Chinese unicorn company BrainCo, he shared perspectives on the strategic direction, opportunities, and key challenges associated with strengthening Korea-China cooperation.
"The Chinese AI healthcare market is currently the fastest-growing in the world and is projected to grow from USD 1.6 billion (approximately KRW 2.3 trillion) in 2023 to USD 19 billion by 2030, representing a compound annual growth rate of 42.5%. We are currently discussing with 15 leading global pharmaceutical companies regarding the use of AI-based biomarkers, currently under joint R&D, as companion diagnostics (CDx) in the Chinese market following their commercial launch," Suh stated.
"I strongly concur with Suh’s statement that the combination of China's speed and scale with Korea's credibility and stability can generate substantial synergy. As the objective of this visit to China is to establish a new, future-oriented framework for bilateral cooperation, the government will provide full support to enable companies from both countries to collaborate effectively and achieve shared growth," President Lee Jae-myung remarked.
Following the summit, Suh participated in the Korea-안전한 바카라 사이트 Investment Conference and the Global Fund Launch Ceremony, where he engaged with venture capital (VC) firms and other institutional investors to explore concrete investment opportunities. He also held meetings with high-potential Chinese companies and discussed in-depth actionable plans to expand bilateral cooperation, including strategies for market development.
Lunit entered the Chinese market in 2020 through the establishment of its local subsidiary, Lunit 안전한 바카라 사이트, in Shanghai. Since then, the company has directly and indirectly supplied its AI-based products to research and laboratory environments via global partners operating in 안전한 바카라 사이트. These partners include Agilent Technologies, a provider of pathology analysis equipment; Labcorp and CellCarta, which operate as contract research organizations (CROs) and diagnostic service providers; and Roche Diagnostics and Indica Labs, both of which specialize in diagnostic software platforms.
Conversely, Lunit has also secured investments from major Chinese and Greater 안전한 바카라 사이트-based investment firms, including Legend Capital and Tybourne Capital, and continues to maintain close, long-term collaborative relationships with Chinese capital.